{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:48:58Z","timestamp":1782276538940,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Climbing Plan of Basic Research Priorities Program of Jiangsu Province","award":["BK20240003"],"award-info":[{"award-number":["BK20240003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00782-4","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:31:23Z","timestamp":1782275483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MAGEC2 promotes tumorigenesis in multiple myeloma through USP16-mediated deubiquitination and stabilization of c-Myc"],"prefix":"10.1186","volume":"15","author":[{"given":"Zihao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"782_CR1","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.phrs.2021.105728","volume":"170","author":"S Wang","year":"2021","unstructured":"Wang S, Fu JL, Hao HF, et al. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res. 2021;170:105728.","journal-title":"Pharmacol Res"},{"key":"782_CR2","doi-asserted-by":"publisher","first-page":"1469178","DOI":"10.3389\/fonc.2024.1469178","volume":"14","author":"X Gou","year":"2024","unstructured":"Gou X, Tang X, Liu C, Chen Z. Ferroptosis: a new mechanism of traditional Chinese medicine for treating hematologic malignancies. Front Oncol. 2024;14:1469178.","journal-title":"Front Oncol"},{"key":"782_CR3","doi-asserted-by":"publisher","first-page":"106442","DOI":"10.1016\/j.phrs.2022.106442","volume":"184","author":"L Soumoy","year":"2022","unstructured":"Soumoy L, Ghanem GE, Saussez S, Journe F. Bufalin for an innovative therapeutic approach against cancer. Pharmacol Res. 2022;184:106442.","journal-title":"Pharmacol Res"},{"issue":"1","key":"782_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13046-021-02220-1","volume":"41","author":"C Gu","year":"2022","unstructured":"Gu C, Wang Y, Zhang L, et al. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma. J Exp Clin Cancer Res. 2022;41(1):11.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"782_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","volume":"39","author":"JM Doyle","year":"2010","unstructured":"Doyle JM, Gao J, Wang J, Yang M, Potts PR. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell. 2010;39(6):963\u201374.","journal-title":"Mol Cell"},{"issue":"21","key":"782_CR6","first-page":"2599","volume":"141","author":"T Du","year":"2023","unstructured":"Du T, Song Y, Ray A, et al. Ubiquitin receptor PSMD4\/Rpn10 is a novel therapeutic target in multiple myeloma. Blood. 2023;141(21):2599\u2013614.","journal-title":"Blood"},{"key":"782_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41571-025-01041-x","volume":"22","author":"MA Dimopoulos","year":"2025","unstructured":"Dimopoulos MA, Terpos E, Boccadoro M, et al. EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma. Nat Rev Clin Oncol. 2025;22:680\u2013700.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"782_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/bjh.13762","volume":"171","author":"N Lajmi","year":"2015","unstructured":"Lajmi N, Luetkens T, Yousef S, et al. Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma. Br J Haematol. 2015;171(5):752\u201362.","journal-title":"Br J Haematol"},{"key":"782_CR9","doi-asserted-by":"publisher","first-page":"922675","DOI":"10.3389\/fcell.2022.922675","volume":"10","author":"Y Liu","year":"2022","unstructured":"Liu Y, Cao B, Hu L, Ye J, Tian W, He X. The Dual Roles of MAGE-C2 in p53 Ubiquitination and Cell Proliferation Through E3 Ligases MDM2 and TRIM28. Front Cell Dev Biol. 2022;10:922675.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"782_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jcp.30941","volume":"238","author":"J Luo","year":"2023","unstructured":"Luo J, Zhao H, Chen L, Liu M. Multifaceted functions of RPS27a: An unconventional ribosomal protein. J Cell Physiol. 2023;238(3):485\u201397.","journal-title":"J Cell Physiol"},{"issue":"1","key":"782_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13046-021-01843-8","volume":"40","author":"J Ge","year":"2021","unstructured":"Ge J, Yu W, Li J, et al. USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stabilizing c-Myc. J Exp Clin Cancer Res. 2021;40(1):59.","journal-title":"J Exp Clin Cancer Res"},{"key":"782_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40164-023-00374-6","volume":"12","author":"A Buratin","year":"2023","unstructured":"Buratin A, Borin C, Tretti Parenzan C, et al. CircFBXW7 in patients with T-cell ALL: depletion sustains MYC and NOTCH activation and leukemia cell viability. Exp Hematol Oncol. 2023;12:12.","journal-title":"Exp Hematol Oncol"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00782-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00782-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00782-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:31:28Z","timestamp":1782275488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40164-026-00782-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00782-4","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Nanjing University of Chinese Medicine. The animal experiments were specifically reviewed and approved by the institution\u2019s Institutional Animal Care and Use Committee (IACUC) (Approval No. 202406A031).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}